Kronox Lab Sciences Approves Q1 FY26 Results, Sets AGM for Sep 16
Kronox Lab Sciences approved its Unaudited Standalone Financial Results for Q1 FY26, reporting total income of ₹2,968.3 Lakhs. The 17th AGM is scheduled for September 16, 2026, with the register of members closed from September 10-16. Internal and Cost Auditors were re-appointed for FY27.
The approval of financial results and the scheduling of the AGM are standard corporate events. The re-appointment of auditors is also a routine procedural matter. The impact is medium as it provides clarity on financial performance and future corporate governance events.
The announcement reports financial results and routine corporate actions like auditor appointments and AGM scheduling. While the results are presented, there are no significant positive or negative triggers mentioned.
Kronox Lab Sciences Limited announced the outcome of its Board of Directors meeting held on August 12, 2026. The Board approved the Unaudited Standalone Financial Results for the quarter ended June 30, 2025. The company reported a total income of ₹2,968.3 Lakhs and a profit before tax of ₹981.0 Lakhs for the quarter.
The Board also decided to convene the 17th Annual General Meeting (AGM) on Wednesday, September 16, 2026. In connection with the AGM and for determining entitlement to final dividend, the Register of Members and Share Transfer Books will be closed from Thursday, September 10, 2026, to Wednesday, September 16, 2026, inclusive.
Furthermore, the company re-appointed M/s. Jaimin & Associates as Internal Auditors for the financial year 2026-27 and appointed M/s. Diwanji & Associates as Cost Auditors for the same period. The Board meeting commenced at 2:30 PM and concluded at 4:30 PM.
What to do with a filing like this
Kronox Lab Sciences Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kronox Lab Sciences Limited. Read the original for the full detail.